No Data
No Data
Telomir Pharmaceuticals Shares Are Trading Higher After the Company Announced Preclinical Results Confirming the Efficacy of Telomir-1.
Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study With Telomir-1
Telomir Pharma Shares Rise 4% After Anti-Aging Drug News
Telomir Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
Telomir Pharmaceuticals Special Advisor Dr. Michael Roizen to Discuss Telomir-1 and the Science of Longevity on Health Uncensored With Dr. Drew on the Fox Business Network This Sunday
Telomir Pharmaceuticals Reaches US$198m Market Cap Benefiting Insider Stock Buying
No Data
No Data